Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Patients With Type IIa or Type IIb Hyperlipidemia
J Am Coll Cardiol Guyton et al.
51: 1564
Online Appendix
Online Appendix
Files in this Data Supplement:
|